Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer

NCT00399529 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

BIOLOGICAL: Allogeneic GM-CSF-secreting breast cancer vaccine
DRUG: Trastuzumab
DRUG: Cyclophosphamide

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]